Wellington Management Group
TVRD

Wellington Management Group’s Tvardi Therapeutics TVRD Stock Holding History

Wellington Management Group’s Portfolio TVRD Stock Details TVRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-320
Closed -$186K – 2075
2019
Q4 		$186K Sell
320
-200
-38% -$140K ﹤0.01% 1984
2019
Q3 		$342K Sell
520
-160
-24% -$133K ﹤0.01% 1928
2019
Q2 		$527K Buy
+680
New +$478K ﹤0.01% 1899
2016
Q2 		– Sell
-2,499
Closed -$559K – 2198
2016
Q1 		$559K Sell
2,499
-1,298
-34% -$388K ﹤0.01% 1930
2015
Q4 		$2.3M Sell
3,797
-392
-9% -$215K ﹤0.01% 1587
2015
Q3 		$2.15M Sell
4,189
-4,383
-51% -$2.93M ﹤0.01% 1614
2015
Q2 		$3.75M Sell
8,572
-778
-8% -$301K ﹤0.01% 1483
2015
Q1 		$3.38M Sell
9,350
-1,572
-14% -$595K ﹤0.01% 1556
2014
Q4 		$3.92M Buy
10,922
+1,477
+16% +$476K ﹤0.01% 1513
2014
Q3 		$2.85M Buy
9,445
+4,118
+77% +$1.69M ﹤0.01% 1595
2014
Q2 		$3.26M Buy
5,327
+199
+4% +$107K ﹤0.01% 1565
2014
Q1 		$3.44M Buy
+5,128
New +$3.03M ﹤0.01% 1566

Other funds holding TVRD

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCP
Rho Capital Partners New York $20.4M AUM
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
C
Chescapmanager Baltimore, Maryland $1.12B AUM 67.49% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wellington Management Group's TVRD Position: Q1 2020 in Review

Wellington Management Group sold out of Tvardi Therapeutics (TVRD) in Q1 2020, closing a stake of 320 shares — an estimated $186K sold.

Wellington Management Group first reported a position in TVRD in Q1 2014 and held it in 12 quarters. The position peaked at $3.92M in Q4 2014. 133 funds tracked by Wall St. Rank hold TVRD as of Q1 2020.

  • Wellington Management Group reported no remaining Tvardi Therapeutics position as of Q1 2020 after selling out during the quarter.
  • Wellington Management Group sold 320 Tvardi Therapeutics shares in Q1 2020, an estimated $186K.
  • Wellington Management Group first reported a position in Tvardi Therapeutics in Q1 2014 and held it in 12 quarters.
  • Wellington Management Group's Tvardi Therapeutics position peaked at $3.92M in Q4 2014.
  • 133 funds tracked by Wall St. Rank held Tvardi Therapeutics as of Q1 2020.

Based on Wellington Management Group's 13F filing for Q1 2020, filed 14 May 2020.